Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Takahide Ara, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Souichi Shiratori, Atsushi Yasumoto, Hideki Goto, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima

Blood (2023) 142 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2023-191306

Published: 2023

Journal Articles

Thrombocytopenia and Low CD4/CD8 Ratio at Apheresis Along with Prior Bendamustine Use Increase Risk of CAR-T Cell Manufacturing Failure

Tomoyasu Jo, Yasuyuki Arai, Satoshi Yoshihara, Minoru Kojima, Junko Ikemoto, Tomoe Uemura, Keita Iwaki, Noboru Yonetani, Shin-ichiro Fujiwara, Masaki Ri, Kaoru Kahata, Tokiko Nagamura-Inoue, Minami Yamada-Fujiwara, Ryuji Tanosaki

Blood (2022) 140 (Supplement 1): 1608–1609.

https://doi.org/10.1182/blood-2022-165613

Published: 2022

Journal Articles

Letermovir Is Effective for Prevention of Cytomegalovirus Reactivation in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Takahide Ara, Yuta Hasegawa, Hiroyuki Ohigashi, Souichi Shiratori, Atsushi Yasumoto, Hideki Goto, Junichi Sugita, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Daigo Hashimoto, Takanori Teshima

Blood (2021) 138 (Supplement 1): 2858.

https://doi.org/10.1182/blood-2021-152116

Published: 2021

Journal Articles

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Hideki Goto, MDPhD, Daisuke Hidaka, MD, Satoshi Yamamoto, MD PhD, Koji Hayasaka, Rie Michimata, Ikuko Kagawa, Kana Sunagoya, Hiroaki Iijima, Eiko Hayase, MD, Souichi Shiratori, MD PhD, Kohei Okada, MD PhD, Junichi Sugita, MD PhD, Masahiro Onozawa, MD PhD, Daigo Hashimoto, MD PhD, Kaoru Kahata, MD PhD, Katsuya Fujimoto, MD PhD, Tomoyuki Endo, MD PhD, Chikara Shimizu, MD PhD, Takanori Teshima, MD PhD

Blood (2017) 130 (Supplement 1): 4478.

https://doi.org/10.1182/blood.V130.Suppl_1.4478.4478

Published: 2017

Journal Articles

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

Takeshi Kondo, MD, PhD, Akio Mori, MD, PhD, Masahiro Onozawa, MD, PhD, Kaoru Kahata, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masanobu Morioka, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2007) 110 (11): 1820.

https://doi.org/10.1182/blood.V110.11.1820.1820

Published: 2007

Journal Articles

HBV Reverse Seroconversion and Intervention with Vaccination after Allogeneic HSCT in Patients with Previous HBV Infection.

Masahiro Onozawa, MD, Hiroe Kanamori, MD, Kaoru Kahata, MD, Takeshi Kondo, MD,PhD, Shuichi Ota, MD,PhD, Satoshi Hashino, MD,PhD, Junji Tanaka, MD,PhD, Masahiro Imamura, MD,PhD, Masahiro Asaka, MD,PhD

Blood (2006) 108 (11): 2921.

https://doi.org/10.1182/blood.V108.11.2921.2921

Published: 2006

Journal Articles

Chimeric Leukemic Protein PLZF/RARα Functions as an Adoptor for Cul3-Based E3 Ubiquitin Ligase To Regulate Proteosomal Degradation of RXRα.

Masahiro Onozawa, MD, Takeshi Kondo, MD, PhD, Hiroe Kanamori, MD, Kaoru Kahata, MD, PhD, Satoshi Hashino, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 1926.

https://doi.org/10.1182/blood.V108.11.1926.1926

Published: 2006

Journal Articles

Clinical Efficacy and Cost Benefit of Low-Dose Granulocyte Colony-Stimulating Factor after Standard Chemotherapy in Patients with Non-Hodgkin’s Lymphoma.

Satoshi Hashino, MD, PhD, Masanobu Morioka, MD, PhD, Tatsuro Irie, MD, PhD, Noriyuki Shiroshita, MD, PhD, Tsugumichi Kawamura, MD, PhD, Sachiko Suzuki, MD, PhD, Hiroshi Iwasaki, MD, PhD, Shintaro Umehara, MD, PhD, Yasutaka Kakinoki, MD, PhD, Mitsutoshi Kurosawa, MD, PhD, Kaoru Kahata, MD, PhD, Koh Izumiyama, MD, PhD, Hajime Kobayashi, MD, Masahiro Onozawa, MD, Mutsumi Takahata, MD, Fumie Fujisawa, MD, Takeshi Kondo, MD, PhD, Masahiro Asaka, MD, PhD

Blood (2006) 108 (11): 4671.

https://doi.org/10.1182/blood.V108.11.4671.4671

Published: 2006

Journal Articles

Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells

Junji Tanaka, Tomomi Toubai, Yutaka Tsutsumi, Yoko Miura, Naoko Kato, Shintarou Umehara, Kaoru Kahata, Akio Mori, Nobuyasu Toyoshima, Shuichi Ota, Takahiko Kobayashi, Masanobu Kobayashi, Masaharu Kasai, Masahiro Asaka, Masahiro Imamura

Blood (2004) 104 (3): 768–774.

https://doi.org/10.1182/blood-2003-11-3870

Published: 2004

NARROW

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Thrombocytopenia and Low CD4/CD8 Ratio at Apheresis Along with Prior Bendamustine Use Increase Risk of CAR-T Cell Manufacturing Failure

Letermovir Is Effective for Prevention of Cytomegalovirus Reactivation in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

A Chimeric Gene, FIP1L1-RARα, Is Isolated from t(4;17)-Positive Acute Promyelocytic Leukemia; a Report of Cloning and Functional Analysis.

HBV Reverse Seroconversion and Intervention with Vaccination after Allogeneic HSCT in Patients with Previous HBV Infection.

Chimeric Leukemic Protein PLZF/RARα Functions as an Adoptor for Cul3-Based E3 Ubiquitin Ligase To Regulate Proteosomal Degradation of RXRα.

Clinical Efficacy and Cost Benefit of Low-Dose Granulocyte Colony-Stimulating Factor after Standard Chemotherapy in Patients with Non-Hodgkin’s Lymphoma.

Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only